Should You Buy DaVita Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, DaVita Inc. (DVA) is rated as a strong fundamental performer with a QOC score of 7.5/10. Trading at $190.90, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.
The short answer: 8 of 10 CirclFi valuation models project upside for DaVita Inc. (DVA) at $190.90 — the model consensus leans bullish, with a Quality Score of 7.5/10 and Value-Trap risk of 12/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for DaVita Inc. (DVA) in 2026?
What Is the Bull Case vs the Bear Case for DaVita Inc. (DVA)?
| Bull case — $1039.76 target (+444.7%) | Bear case — $58.29 target (-69.5%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, DaVita Inc.'s rating of 7.5/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably. | According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $58.29 (-69.5%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, 8 of 10 models identify upside from $190.90 to a median fair value of $295.53, indicating the market hasn't fully priced in DaVita Inc.'s earnings power. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +514.1% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
| According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model targets a fair value of $1,039.76 (+444.7%), anchoring the bull case with a methodology that evaluates base, bull, and bear scenarios simultaneously. |
How Does DVA Compare to Its Medical Care Facilities Peers?
Valuation data pages: GRDN · CON · BTMD · FMS · HCSG · JYNT · RHEP · SNDA · UHS · ADUS · NHC
Which Other Stocks Score Like DVA on Quality?
Closest companies to DVA’s Quality of Company score of 7.5/10, across all industries.
- MICC — The Magnum Ice Cream Company N.V. (QOC 7.5) · analysis
- NOK — Nokia Oyj (QOC 7.5) · analysis
- SIBN — SI-BONE, Inc. (QOC 7.5) · analysis
- AMRC — Ameresco, Inc. (QOC 7.5) · analysis
- BRKR — Bruker Corporation (QOC 7.5) · analysis
- VTS — Vitesse Energy, Inc. (QOC 7.5) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Care Facilities Screens Does DVA Appear In?
So Is DaVita Inc. (DVA) Worth Buying in 2026?
DaVita Inc. at $190.90 presents what our engine identifies as a high-conviction opportunity: 8 of 10 models see upside, quality stands at 7.5/10, and the median fair value of $295.53 implies +54.8% return potential. Investors should verify this thesis against their own risk parameters and time horizon.
These are quantitative model outputs, not investment recommendations. DaVita Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About DVA Stock?
Should I buy DVA stock right now?
Based on CirclFi's multi-model analysis, 8 of 10 models see upside for DVA at $190.90. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.5/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in DaVita Inc.?
Key risks include: wide model disagreement (1684% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.
How does DVA compare to its competitors?
Among Medical Care Facilities peers, DVA holds a Quality Score of 7.5/10. Comparable companies include GRDN (QOC 7.6), CON (QOC 7.5), BTMD (QOC 7.6). The relative ranking helps investors identify whether DVA offers better fundamental quality than alternatives in the same sector.
Is DVA a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. DVA's Quality Score of 7.5/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy DVA at?
CirclFi does not provide target buy prices or price alerts. However, our 10 active models produce fair value estimates ranging from $58.29 to $1039.76. At $190.90, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for DVA.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad